MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$49,970K
Free Cash flow
-$49,871K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Share-based compensation expense
Depreciation and amortization
Operating lease right-of-use ass...
Others
Negative Cash Flow Breakdown
Net loss
Research and development incenti...
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-50,333
-60,825
-20,154
-59,100
Share-based compensation expense
6,404
6,930
11,653
8,771
Depreciation and amortization
1,067
1,129
1,336
1,756
Deferred income tax provision (benefit)
326
-241
843
-46
Research and development incentives receivable
6,516
6,040
-31,287
7,614
Prepaid expenses and other assets
-469
-191
-4,130
1,375
Operating lease right-of-use assets
-588
-1,111
-1,190
-1,172
Accounts payable
-59
-3,838
-2,881
-5,070
Accrued expenses and other current liabilities
-597
-2,353
2,000
1,121
Operating lease liabilities
-711
-1,283
-1,410
-1,390
Deferred revenue
-244
-706
-47,340
-9,398
Net cash used in operating activities
-49,606
-65,925
-19,346
-71,173
Purchases of property and equipment
265
713
574
674
Net cash used in investing activities
-265
-713
-574
-674
Proceeds from the exercise of share options and settlement of restricted share units
1
12
33
1
Payments of finance lease obligations
51
66
48
31
Net cash used in financing activities
-50
-54
-15
-30
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-49
-1,944
-222
-1,249
Net decrease in cash, cash equivalents and restricted cash
-49,970
-68,636
-20,157
-73,126
Cash, cash equivalents and restricted cash at beginning of period
560,079
628,715
648,872
880,067
Cash, cash equivalents and restricted cash at end of period
510,109
560,079
628,715
648,872
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in
cash, cash...
-$49,970K
(68.39%↑ Y/Y)
Share-based compensation
expense
$6,404K
(-66.37%↓ Y/Y)
Depreciation and
amortization
$1,067K
(-67.96%↓ Y/Y)
Operating lease
right-of-use assets
-$588K
(73.69%↑ Y/Y)
Prepaid expenses and
other assets
-$469K
(-105.47%↓ Y/Y)
Deferred income tax
provision (benefit)
$326K
(119.79%↑ Y/Y)
Proceeds from the
exercise of share options...
$1K
(-66.67%↓ Y/Y)
Net cash used in
operating activities
-$49,606K
(68.83%↑ Y/Y)
Net cash used in
investing activities
-$265K
(75.95%↑ Y/Y)
Net cash used in
financing activities
-$50K
(41.86%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$49K
(-102.15%↓ Y/Y)
Canceled cashflow
$8,854K
Canceled cashflow
$1K
Net loss
-$50,333K
(63.97%↑ Y/Y)
Purchases of property and
equipment
$265K
(-75.95%↓ Y/Y)
Payments of finance lease
obligations
$51K
(-42.70%↓ Y/Y)
Research and development
incentives receivable
$6,516K
(-68.64%↓ Y/Y)
Operating lease
liabilities
-$711K
(73.23%↑ Y/Y)
Accrued expenses and
other current...
-$597K
(-161.42%↓ Y/Y)
Deferred revenue
-$244K
(98.04%↑ Y/Y)
Accounts payable
-$59K
(-105.46%↓ Y/Y)
Buy us a coffee
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)